543916 — Hemant Surgical Industries Cashflow Statement
0.000.00%
- IN₹1.04bn
- IN₹1.25bn
- IN₹1.07bn
- 59
- 61
- 14
- 40
Annual cashflow statement for Hemant Surgical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 15.2 | 34 | 101 | 128 | 105 |
Depreciation | |||||
Non-Cash Items | 16.5 | 33 | 29.1 | -1.9 | 25.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -40.7 | 74.3 | -78.2 | -212 | -56 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.71 | 155 | 60 | -75.6 | 88.4 |
Capital Expenditures | -23.9 | -4.23 | -39.3 | -55.2 | -376 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.599 | 17.5 | 9.61 | -34.5 | 73 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -23.3 | 13.3 | -29.7 | -89.7 | -303 |
Financing Cash Flow Items | -1.13 | -46.7 | -19.1 | -9.45 | -21.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.17 | -111 | -3.94 | 212 | 176 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -20.8 | 57 | 26.3 | 47.1 | -37.9 |